References
- Abcam (2016) IHC-Paraffin Protocol (IHC-P). http://www.abcam.com/ps/pdf/protocols/ihc_p.pdf (accessed on February 15, 2016).
- Baker M, Reynolds HM, Lumicisi B, Bryson CJ (2010) Immunogenicity of protein therapeutics: the key causes, consequences and challenges. Self/Nonself 1: 314–322.
- Cesta M (2006) Normal structure, function, and histology of the spleen. Toxicol. Pathol. 34: 455–465.
- Delves PJ, Martin SJ, Burton DR, Roitt IM (2011) Roitt’s Essential Immunology. 12th ed. Wiley-Blackwell, New York. pp. 6–7.
- Espin JC, Soler-Rivas C, Wichers HJ (2000) Maturation and activation of latent tyrosinase from Agaricus bisporus. Mushroom Sci. 15: 79–86.
- Fujinaga Y (2010) Interaction of botulinum toxin with the epithelial barrier. J. Biomed. Biotechnol. 2010: 974943–974951.
- Hoffman WP, Ness DK, van Lier RBL (2002) Analysis of rodent growth data in toxicology studies. Toxicol. Sci. 66: 313–319.
- Ismaya WT, Rozeboom HJ, Weijn A, Mes JJ, Fusetti F, Wichers HJ, Dijkstra BW (2011) Crystal structure of Agaricus bisporus mushroom tyrosinase: identity of the tetramer subunits and interaction with tropolone. Biochemistry 50: 5477–5486.
- Ismaya WT, Yunita, Damayanti S, Caroline, Tjandrawinata RR, Retnoningrum DS, Rachmawati H (2016a) In silico study to develop a lectin-like protein from mushroom agaricus bisporus for pharmaceutical application. Sci. Pharm. 84: 203–217.
- Ismaya WT, Yunita, Efthyani A, Lai X, Retnoningrum DS, Rachmawati H, Dijkstra BW, Tjandrawinata RR (2016b) A novel immune-tolerable and permeable lectin-like protein from mushroom Agaricus bisporus. Biochem. Biophys. Res. Commun. 473: 1090–1093.
- Ismaya WT, Tandrasasmita OM, Sundari S, Lai X, Retnoningrum DS, Dijkstra BW, Tjandrawinata RR, Rachmawati H (2017) The light subunit of mushroom Agaricus bisporus tyrosinase: its biological characteristics and implications. Int. J. Biol. Macromol. 102: 306–314.
- Ito H, Sagane Y, Miyata K, Inui K, Matsuo T, Horiuchi R, Ikeda T, Suzuki T, Hasegawa K, Kouguchi H, Oguma K, Niwa K, Ohyama T, Watanabe T (2011) HA-33 facilitates transport of the serotype D botulinum toxin across a rat intestinal epithelial cell monolayer. FEMS Immunol. Med. Microbiol. 61: 323–331.
- Lai X, Soler-Lopez M, Ismaya WT, Wichers HJ, Dijkstra BW (2016) Crystal structure of recombinant MtaL at 1.35 angstrom resolution. Acta Cryst. 72: 244–250.
- Nakamura T, Tonozuka T, Ide A, Yuzawa T, Oguma K, Nishikawa A (2008) Sugar binding sites of the HA1 subcomponent of Clostridium botulinum type C progenitor toxin. J. Mol. Biol. 376: 854–867.
- Sayadmanesh A, Ebrahimi F, Hajizade A, Rostamian M, Keshavarz H (2013) Expression and purification of neurotoxin-associated protein HA-33/A from Clostridium botulinum and evaluation of its antigenicity. Iran Biomed. J. 17: 165–170.
- Schlenk D, Handy R, Steinert S, Depledge MH, Benson W (2008) Biomarkers. In: Richard T, Di Guilio DEH, Eds. The Toxicology of the Fishes, CRC Press, Boca Raton, FL. pp. 703–706.
- Singh S, Wasson S (2008) Drug toxicity research trends. In: Vellotis CE, Ed. Drug Toxicity: New Research, Nova Science Publishers Inc., New York. pp. 11–12.
- Vera-Cabrera L, Rendon A, Diaz-Rodriguez M, Handzel V, Laszlo A (1999) Dot blot assay for detection of antidiacyltrehalose antibodies in tuberculous patients.Clin. Diagn. Lab. Immunol. 6: 686–689.